Breaking News

Eurofins Genomics US Expands Gene Synthesis Capabilities

Acquires Blue Heron Biotech, known for expertise in gene synthesis and sub cloning

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Eurofins Genomics LLC (US) has acquired Blue Heron Biotech, a company specializing in advanced gene synthesis. The acquisition provides synergies for both companies due to the inherent connection between their main product segments—oligonucleotides, sequencing and synthetic genes, and strengthens Eurofins Genomics offer in the synthetic biology market.   Blue Heron is known for their expertise in gene synthesis and sub cloning, which allows them to construct sizable gene constructs. Since DNA ol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters